Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma

被引:0
|
作者
Wang, Weiwei [1 ]
He, Zhiguo [1 ]
Jia, Haowen [2 ]
Zhang, Jiansheng [1 ]
Qi, Feng [3 ]
机构
[1] Tianjin Med Univ, Baodi Clin Coll, Dept Gen Surg, 8 Guangchuan Rd, Tianjin 301800, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Airport Hosp, Dept Gen Surg, Tianjin, Peoples R China
[3] Tianjin Med Univ Gen Hosp, Dept Gen Surg, 154 Anshan Rd, Tianjin 300052, Peoples R China
基金
中国国家自然科学基金;
关键词
Cuproptosi; gene signature; hepatocellular carcinoma (HCC); prognostic analysis; immune infiltration; PYRUVATE-DEHYDROGENASE COMPLEX; CELL-DEATH; COPPER DEFICIENCY; OXIDATIVE STRESS; CANCER; DISULFIRAM; INHIBITION; DRUG; MITOCHONDRIA; EXPRESSION;
D O I
10.21037/tcr-23-1561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hepatocellular carcinoma (HCC) of which its prognostic prediction is still unclarified is a highly heterogeneous disease. Cuproptosis is a form of cell death that depends on copper regulation. Whether the cuproptosis-related genes can be the prognostic indicators of HCC is yet to be elucidated. The aim of this study is to investigate whether cuproptosis-related genes play a role in HCC and can be used as a diagnostic index to predict the occurrence of liver cancer. Methods: We downloaded HCC patients' gene expression profiles and their corresponding clinical data from a public database. To screen data, we used single factor Cox regression analysis, meanwhile, polymerase chain reaction (PCR) was used for the verification. After that, the risk score was calculated and the relationship between risk score and clinical factors was analyzed. Besides, a nomogram map was constructed for predicting the prognosis of HCC, and calibration map and decision curve analysis (DCA) map were used to test the model. Results: Compared to the high expression group of four cuproptosis-related genes, the low expression group showed better overall survival (OS) [hazard ratio (HR) =2.58; 95% confidence interval (CI): 1.72-3.89, P<0.001]. The expression of the four cuproptosis-relate genes increased in liver cancer cell lines compared to liver cell lines (P<0.05). Based on these four genes, we calculated the risk score and divided them into two groups as high-risk group and low-risk group. The risk factor map showed the high-risk group had shorter survival time and the four genes were highly expressed. The area under curve (AUC) of receiver operating characteristic (ROC) prediction curve for the first year was 0.726. Risk scores were closely related to clinical factors and immune cells. Finally, we constructed a nomogram for predicting the prognosis of HCC. Conclusions: The risk score for cuproptosis-related genes was established and involved in the construction of the nomogram, providing a new perspective on the prognosis and copper metabolism of HCC.
引用
收藏
页码:2985 / 3002
页数:18
相关论文
共 50 条
  • [41] Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
    Liu, Zijian
    Zhu, Fubin
    Zhang, Pu
    Qian, Bei
    Liu, Weihui
    Xiao, Yajun
    Chen, Nianyong
    He, Qingliu
    Xiao, Jianghong
    FRONTIERS IN GENETICS, 2022, 13
  • [42] Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
    Wang, Yu
    Xiao, Xu
    Li, Yan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
    Yu Wang
    Xu Xiao
    Yan Li
    Scientific Reports, 13
  • [44] Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA
    Ling, Xiaodong
    Zhang, Luquan
    Fang, Chengyuan
    Liang, Hao
    Zhu, Jinhong
    Ma, Jianqun
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (04) : 754 - 769
  • [45] Prognostic and metabolic characteristics of a novel cuproptosis-related signature in patients with hepatocellular carcinoma
    Qu, Xin
    Meng, Ling-cui
    Lu, Xi
    Chen, Xian
    Li, Yong
    Zhou, Rui
    Zhu, Yan-juan
    Luo, Yi-chang
    Huang, Jin-tao
    Shi, Xiao-liang
    Zhang, Hai-Bo
    HELIYON, 2024, 10 (01)
  • [46] Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
    He, Fengjiao
    Zeng, Puhua
    Ma, Sijing
    Yang, Ximing
    Liu, Huan
    Liu, Qiong
    Zhou, Yangying
    Zhu, Hong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Cuproptosis-related lncRNAs emerge as a novel signature for predicting prognosis in prostate carcinoma and functional experimental validation
    Lu, Yangbai
    Wu, Jinfeng
    Li, Xianzhe
    Leng, Qu
    Tan, Jian
    Huang, Hongxing
    Zhong, Rui
    Chen, Zhenjie
    Zhang, Yongxin
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
    Luo, Bixian
    Lin, Jianwei
    Ni, Anqi
    Cai, Wei
    Yu, Xinbo
    Wang, Mingliang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
    Zhang, Huizhe
    Shi, Yanchen
    Yi, Qing
    Wang, Cong
    Xia, Qingqing
    Zhang, Yufeng
    Jiang, Weilong
    Qi, Jia
    FRONTIERS IN GENETICS, 2022, 13
  • [50] Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
    Liu, Chunhua
    Wu, Simin
    Lai, Liying
    Liu, Jinyu
    Guo, Zhaofu
    Ye, Zegen
    Chen, Xiang
    BMC BIOINFORMATICS, 2023, 24 (01)